Compare

Hawkins/$HWKN

1D1W1M3M6MYTD1Y5YMAX

About Hawkins

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The Industrial Solutions segment, provides industrial chemicals, products and services to industries such as industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing. The water treatment segment, which generates the majority of revenue sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. Food and Health Sciences segment specializes in processing and formulation solutions as well as ingredient distribution to manufacturers in the nutrition, food, pharmaceutical, and agricultural markets.
Ticker
$HWKN
Sector
Materials
Primary listing
NASDAQ
Employees
1,200
Headquarters
Roseville, United States
Website
www.hawkinsinc.com

Hawkins Metrics

BasicAdvanced
$3.2B
36.93
$4.12
0.74
$0.77
0.53%

What the Analysts think about Hawkins

Analyst ratings (Buy, Hold, Sell) for Hawkins stock.
Analyst projections of the future price of Hawkins stock.

Bulls say / Bears say

Hawkins posted record second-quarter revenue, gross profit and EPS: sales rose 12%, including 11% organic growth, and diluted EPS increased 23%. All three segments grew, with Water Treatment sales up 16%. (Hawkins, Inc.)
Recent Water Treatment acquisitions extend Hawkins’ reach and product capabilities, including a new presence in Dallas–Fort Worth and added customer reach in Florida. These bolt-ons give the company more routes to serve a core growth segment. (Hawkins, Inc., Hawkins, Inc.)
Cash generation is helping Hawkins fund investment while reducing leverage: first-half free cash flow rose 14%, and the company paid down $15 million of debt and repurchased $18.6 million of shares. Its leverage ratio fell to 1.22 times adjusted EBITDA from 1.54 times a year earlier. (Hawkins, Inc.)
Raw-material and freight costs remain a margin risk. Hawkins said higher raw-material costs increased its LIFO expense and higher fuel costs were not fully recovered through freight charges in the latest quarter. (Hawkins, Inc.)
Food & Health Sciences sales grew 5% in the second quarter, but gross profit fell 4% and its margin slipped to 19% from 21%. Hawkins attributed the decline to lower margins in food and pharmaceutical products, highlighting weakness beneath the segment’s revenue growth. (Hawkins, Inc.)
The shares may leave limited room for disappointment: Barclays described Hawkins’ valuation as full at about 19 times EV/EBITDA against an earnings-growth outlook of roughly 6.5%. The firm also pointed to raw-material volatility and cyclical end-market exposure as risks to the risk-reward balance. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 27 Oct 2026.

Hawkins Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Hawkins Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Hawkins

Funds
Fund name
Fund size
$HWKN weighting
iShares Global Water€IQQQ
$2.1B0.52%
iShares Global Water£IH2O
$2.1B0.52%
iShares S&P Small Cap 600£ISP6
$2.5B0.18%
iShares S&P SmallCap 600$IDP6
$2.5B0.18%
SPDR S&P US Dividend Aristocrats£USDV
$3.6B0.13%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.